Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis

References 

1. Brochier ML, Arwidson P. Coronary heart disease risk factors in women. Eur Heart J. 1998;19(suppl A):A45–A52
2. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior?. Circulation. 1997;95:252–264
   • MEDLINE
3. Fitzpatrick LA. Gender-related differences in the development of atherosclerosis: studies at the cellular level. Clin Exp Pharmacol Physiol. 1996;23:267–269
   • MEDLINE
   • CrossRef
4. Hennekens CH. Risk factors for coronary heart disease in women. Cardiol Clin. 1998;16:1–8
   • Abstract
   • Full Text
   • Full-Text PDF (717 KB)
   • CrossRef
5. Jousilahti P, Vartiainen E, Tuomilehto J, et al.  Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999;99:1165–1172
   • MEDLINE
6. Kannel WB, Wilson PW, D’Agostino RB, et al.  Sudden coronary death in women. Am Heart J. 1998;136:205–212
   • Abstract
   • Full Text
   • Full-Text PDF (189 KB)
   • CrossRef
7. Wenger NK. An update on coronary heart disease in women. Int J Fertil Women Med. 1998;43:84–90
8. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990;81:1680–1687
   • MEDLINE
   • CrossRef
9. Caulin-Glaser T, Farrell WJ, Pfau SE, et al.  Modulation of circulating cellular adhesion molecules in postmenopausal women with coronary artery disease. J Am Coll Cardiol. 1998;31:1555–1560
   • Abstract
   • Full Text
   • Full-Text PDF (138 KB)
   • CrossRef
10. Frazier-Jessen MR, Kovacs EJ. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol. 1995;154:1838–1845
    • MEDLINE
11. Hulley S, Grady D, Bush T, et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605–613
    • MEDLINE
    • CrossRef
12. Women’s Health Initiative Study Group . Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials. 1998;19:61–109
    • Abstract
    • Full Text
    • Full-Text PDF (397 KB)
    • CrossRef
13. Burke AP, Farb A, Malcom GT, et al.  Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation. 1998;97:2110–2116
    • MEDLINE
14. Burke AP, Farb A, Malcom GT, et al.  Coronary risk factors and plaque morphology in patients with coronary disease dying suddenly. N Engl J Med. 1997;336:1276–1282
    • MEDLINE
    • CrossRef
15. Dollar AL, Kragel AH, Fernicola DJ, et al.  Composition of atherosclerotic plaques in coronary arteries in women less than 40 years of age with fatal coronary artery disease and implications for plaque reversibility. Am J Cardiol. 1991;67:1223–1227
    • MEDLINE
    • CrossRef
16. Mautner SL, Lin F, Mautner GC, et al.  Comparison in women versus men of composition of atherosclerotic plaques in native coronary arteries and in saphenous veins used as aortocoronary conduits. J Am Coll Cardiol. 1993;21:1312–1318
    • Abstract
    • Full-Text PDF (2875 KB)
    • CrossRef
17. Taylor AJ, Burke AP, O’Malley PG, et al.  A comparison of the Framingham risk index, coronary artery calcification, and culprit plaque morphology in sudden cardiac death. Circulation. 2000;101:1243–1248
18. Farb A, Tang A, Burke A, et al.  Sudden coronary death: frequency of active coronary lesions, inactive coronary lesions, and myocardial infarction. Circulation. 1995;92:1701–1709
    • MEDLINE
19. Farb A, Burke AP, Tang A, et al.  Coronary plaque erosion without rupture into a lipid core: a frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;93:1354–1363
    • MEDLINE